CompletedPhase 3NCT02279498
SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis
Studying Rare pancreatic disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Anthera Pharmaceuticals
- Principal Investigator
- Monica GangalAnthera Pharmaceuticals
- Intervention
- Liprotamase(drug)
- Enrollment
- 128 enrolled
- Eligibility
- 7 years · All sexes
- Timeline
- 2015 – 2017
Study locations (30)
- Investigator Site 123, Long Beach, California, United States
- Investigator Site 107, Los Angeles, California, United States
- Investigator Site 114, Aurora, Colorado, United States
- Investigator Site 120, Gainesville, Florida, United States
- Investigator Site 102, Jacksonville, Florida, United States
- Investigator Site 130, Miami, Florida, United States
- Investigator Site 117, Orlando, Florida, United States
- Investigator Site 110, Atlanta, Georgia, United States
- Investigator Site 127, Chicago, Illinois, United States
- Investigator Site 109, Glenview, Illinois, United States
- Investigator Site 104, Indianapolis, Indiana, United States
- Investigator Site 105, Wichita, Kansas, United States
- Investigator Site 128, Lexington, Kentucky, United States
- Investigator Site 122, Louisville, Kentucky, United States
- Investigator Site 132, Portland, Maine, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02279498 on ClinicalTrials.gov